Piper Jaffray Raises Price Target on Abiomed (ABMD) Following 1Q16
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall Street futures fall as oil, Treasury yields rise on Iran tensions
- Oil prices fall after hitting over one-month high; traders weigh supply risks
- Dell again lifts annual forecasts as AI demand powers record results
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
- Berkshire’s Abel says data centers are energy opportunity
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- S&P Global shares rise on report of possible CapIQ spinoff
Abiomed to Hold Investor Day in Boston on August 11
August 5, 2015 8:01 AM EDTDANVERS, Mass., Aug. 05, 2015 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD) announced today that the Company will webcast presentations at its Investor Day held in Boston, MA on Tuesday, August 11, 2015, from 9:00 a.m. to approximately 12:00 p.m. EDT.Â
Abiomed will host a physician panel of experts, present our corporate strategy and 5 year revenue projection, describe a new patient population of interest and unveil a future product for heart failure.
... MoreAbiomed Announces Q1 FY 2016 Revenue of $73.4 Million, Up 50% Over Prior Year
August 4, 2015 7:00 AM EDTDANVERS, Mass., Aug. 04, 2015 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2016 revenue of $73.4 million, an increase of 50% compared to revenue of $48.8 million for the same period of fiscal 2015. First quarter fiscal 2016 GAAP net income was $8.9 million or $0.20 per diluted share, compared to GAAP net loss of $1.7 million or a loss of $0.04 per diluted share for... More
